Bailard’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Bailard’s Portfolio DBTX Stock Details DBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,600	Closed	-$40.8K	–	795
2023 Q2	$40.8K	Buy	+10,600	New	+$38.9K	﹤0.01%	683
2022 Q2	–	Sell	-19,700	Closed	-$60K	–	835
2022 Q1	$60K	Buy	+19,700	New	+$75.5K	﹤0.01%	706

Other funds holding DBTX

ACA

Atlas Capital Advisors Jackson, Wyoming $914M AUM

Bailard's DBTX Position: Q3 2023 in Review

Bailard sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 10,600 shares — an estimated $40.8K sold.

Bailard first reported a position in DBTX in Q1 2022 and held it in 2 quarters. The position peaked at $60K in Q1 2022. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

Bailard reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Bailard sold 10,600 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $40.8K.
Bailard first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
Bailard's Decibel Therapeutics, Inc. Common Stock position peaked at $60K in Q1 2022.
1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Bailard's 13F filing for Q3 2023, filed 24 Oct 2023.